Buy SS-31 Nasal Spray New Zealand
SS-31 nasal spray facilitates ATP synthesis to improve mitochondrial activity and total energy generation. According to New Zealand research, this supplement may lower the inflammatory cytokines associated with Alzheimer’s, Parkinson’s, cardiovascular, diabetes, and renal disease.
SS-31 nasal spray is a short peptide capable of penetrating mitochondria and influencing the maintenance of mitochondrial activity. SS-31 is a member of a class of cell-penetrating peptides that accumulate and target the inner mitochondrial membrane. The peptide repairs the mitochondria by binding to cardiolipin, an essential part of the mitochondria’s inner membrane.
Neuroprotective Advantages:
SS-31 protects against anaesthesia-induced cognitive problems and promotes mitochondrial function, synaptic health, and wellness in mice. But no research studies have tested its neuroprotective results in humans.
Ageing and associated health problems:
Preliminary findings from temporary phase I/II clinical trials recommend a possible benefit of SS-31 in patients with cardiac arrest. Research studies are required to confirm this.
Research findings
The Szeto-Schiller peptide SS-31, also called Bendavid, mainly interacts with CL to change the shape of the membrane layer and stop the damage from peroxidation. It has exhibited promising results in preclinical testing as a potential treatment for mitochondrial diseases and heart failure.
New Zealand Research shows that this mitochondrial antioxidant peptide can eliminate oxidants and raise ATP levels, which keeps mitochondrial membrane potential (MMP) stable.
A recent study revealed a correlation between reducing neuroinflammation and increasing functional connectivity (FC) within hippocampus-relevant brain areas. This association was observed in hippocampus-relevant areas.
In addition, the New Zealand study indicated that early administration of the anti-inflammatory drug SS-31 nasal spray has a long-lasting effect on lowering the effects of lipopolysaccharide (LPS)-induced neuroinflammation. This was evidenced by the fact that early administration of SS-31 significantly reduced LPS-induced neuroinflammation.
Benefits of SS-31
The impact of SS-31 on mitochondrial activity and maintenance is being studied to determine its benefits on human health. New Zealand Researchers have recently uncovered at least four promising advantages that may make it a valuable treatment for a wide range of conditions:
- Ability to reverse mitochondrial dysfunction
- Help increase endurance
- Help with cognitive impairment
- Reduces risk of heart disease
- SS-31 Nasal Spray offers a convenient way of gaining all the advantages this peptide has to offer without the use of needles.
References:
https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1627-9
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192202/
https://pubmed.ncbi.nlm.nih.gov/26944333/
https://pubmed.ncbi.nlm.nih.gov/23813215/
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.
